A new dawn for the use of traditional Chinese medicine in cancer therapy

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Parekh, Harendra S ^a   Liu, Gang ^b   Wei, Ming Q ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; BERBAMINE; CASPASE; CASPASE 3 INHIBITOR; CURCUMIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOMYCIN C; PACLITAXEL; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTEMISIA ABSINTHIUM; BERBERIS; CAMPTOTHECA; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER THERAPY; CELL PROLIFERATION; CHINESE MEDICINE; CONCENTRATION RESPONSE; CURCUMA LONGA; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PLANT; PLANT ROOT; PROTEIN FUNCTION; QUALITY OF LIFE; RABDOSIA; REVIEW; RHIZOMA ZEDOARIA; SCUTELLARIA BAICALENSIS; TREATMENT RESPONSE; TUMOR GROWTH; METHODOLOGY; NEOPLASM;

ANIMALIA;

APOPTOSIS; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 64249169883     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-21     Document Type: Review

References (93)

1. Taiwan: Time to end the exile Lancet 1999, 354:2093-2093 10609807
2. Igney FH Krammer PH Death and anti-death: Tumour resistance to apoptosis Nature Reviews Cancer 2002, 2:277-288 12001989
3. Schmitz I Kirchhoff S Krammer PH Regulation of death receptor-mediated apoptosis pathways Int J Biochem Cell Biol 2000, 32:1123-1136 11137452
4. Kwon K-B Park B-H Ryu D-G Chemotherapy through mitochondrial apoptosis using nutritional supplements and herbs: A brief overview J Bioenerg Biomembr 2007, 39:31-34 17549640
5. Klein G Cancer, apoptosis, and nonimmune surveillance Cell Death Differ 2004, 11:13-17 14615800
6. Ruan W-J Lai M-D Zhou J-G Anticancer effects of Chinese herbal medicine, science or myth? Journal of Zhejiang University, Science, B 2006, 7:1006-1014.
7. Luk JM Wang X Liu P Wong K-F Chan K-L Tong Y Hui C-K Lau GK Fan S-T Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: From laboratory discovery to clinical evaluation Liver Int 2007, 27:879-890. 17696925
8. Green DR Evan GI A matter of life and death Cancer Cell 2002, 1:19-30. 12086884
9. Petit PX Susin SA Zamzami N Mignotte B Kroemer G Mitochondria and programmed cell death: Back to the future FEBS Lett 1996, 396:7-13. 8906857
10. Bossy-Wetzel E Green DR Apoptosis: Checkpoint at the mitochondrial frontier Mutation Research, DNA Repair 1999, 434:243-251.
11. Rathmell JC Thompson CB The central effectors of cell death in the immune system Annu Rev Immunol 1999, 17:781-828. 10358774
12. Janssen-Heininger YMW Poynter ME Baeuerle PA Recent advances towards understanding redox mechanisms in the activation of nuclear factor kb Free Radical Biology & Medicine 2000, 28:1317-1327. 10924851
13. Baeuerle PA Henkel T Function and activation of NF-kappa B in the immune system Annu Rev Immunol 1994, 12:141-179. 8011280
14. Baeuerle PA Rupec RA Pahl HL Reactive oxygen intermediates as second messengers of a general pathogen response Pathologie Biologie 1996, 44:29-35. 8734297
15. Pahl HL Activators and target genes of Rel/NF-kappa B transcription factors Oncogene 1999, 18:6853-6866. 10602461
16. Shishodia S Aggarwal BB Nuclear factor-kappa B activation: A question of life or death J Biochem Mol Biol 2002, 35:28-40. 16248967
17. Li BQ Fu T Gong WH Dunlop N Kung HF Yan YD Kang J Wang JM The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines Immunopharmacology 2000, 49:295-306. 10996027
18. Chi YS Lim H Park H Kim HP Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: In vivo regulation of inflammation-associated gene expression Biochem Pharmacol 2003, 66:1271-1278. 14505806
19. Yu HQ Rafi MM Ho CT Targeting inflammation using Asian herbs Herbs: Challenges in Chemistry and Biology Oxford: Oxford University Press Ho CT 2006:266-280.
20. Tan BKH Vanitha J Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: A review Curr Med Chem 2004, 11:1423-1430. 15180575
21. Nelson PS Montgomery B Unconventional therapy for prostate cancer: Good, bad or questionable? Nature Reviews Cancer 2003, 3:845-858. 14668815
22. Po LS Chen ZY Tsang DSC Leung LK Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells Cancer Lett 2002, 187:33-40. 12359348
23. Powell CB Fung P Jackson J Dall'Era J Lewkowicz D Cohen I Smith-McCune K Aqueous extract of herb Scutellaria barbatae, a Chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines Gynecol Oncol 2003, 91:332-340. 14599863
24. Ye F Xui L Yi JZ Zhang WD Zhang DY Anticancer activity of Scutellaria baicalensis and its potential mechanism J Altern Complement Med 2002, 8:567-572. 12470437
25. Pidgeon GP Kandouz M Meram A Honn KV Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells Cancer Res 2002, 62:2721-2727. 11980674
26. Burnett BP Jia Q Zhao Y Levy RM A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation J Med Food 2007, 10:442-451. 17887937
27. Chan FL Choi HL Chen ZY Chan PSF Huang Y Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin Cancer Lett 2000, 160:219-228. 11053652
28. Kwon K-B Kim E-K Shin B-C Seo E-A Park J-W Kim J-S Park B-H Ryu D-G Induction of apoptosis by takrisodokyeum through generation of hydrogen peroxide and activation of caspase-3 in HL-60 cells Life Sci 2003, 73:1895-1906. 12899915
29. Sahara S Aoto M Eguchi Y Imamoto N Yoneda Y Tsujimoto Y Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation Nature 1999, 401:168-173. 10490026
30. Sebbagh M Renvoize C Hamelin J Riche N Bertoglio J Breard J Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing Nat Cell Biol 2001, 3:346-352. 11283607
31. Kwon KB Kim EK Han MJ Shin BC Park YK Kim KS Lee YR Park JW Park BH Ryu DG Induction of apoptosis by Radix Paeoniae alba extract through cytochrome c release and the activations of caspase-9 and caspase-3 in HL-60 cells Biol Pharm Bull 2006, 29:1082-1086. 16754997
32. DiPietrantonio AM Hsieh T-C Wu JM Activation of caspase 3 in HL-60 cells exposed to hydrogen peroxide Biochem Biophys Res Commun 1999, 255:477-482. 10049734
33. Sung HJ Choi SM Yoon Y An KS Tanshinone IIA, an ingredient of Salvia miltiorrhiza bunge, induces apoptosis in human leukemia cell lines through the activation of caspase-3 Exp Mol Med 1999, 31:174-178. 10630370
34. Yoon Y Kim YO Jeon WK Park JH Sung HJ Tanshinone IIA isolated from Salvia miltiorrhiza bunge induced apoptosis in HL60 human premyelocytic leukemia cell line J Ethnopharmacol 1999, 68:121-127. 10624871
35. Lee H Kim YJ Kim HW Lee DH Sung M-K Park T Induction of apoptosis by Cordyceps militaris through activation of caspase-3 in leukemia HL-60 cells Biol Pharm Bull 2006, 29(4):670-674. 16595897
36. Liu WK Cheung FWK Che C-T Stellettin A Induces Oxidative Stress and Apoptosis in HL-60 Human Leukemia and LNCaP Prostate Cancer Cell Lines J Nat Prod 2006, 69:934-937. 16792413
37. Walczak H Miller RE Ariail K Gliniak B Griffith TS Kubin M Chin W Jones J Woodward A Le T et al. Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo Nat Med 1999, 5:157-163. 9930862
38. Nagane M Pan GH Weddle JJ Dixit VM Cavenee WK Huang HJS Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo Cancer Res 2000, 60:847-853. 10706092
39. Chinnaiyan AM Prasad U Shankar S Hamstra DA Shanaiah M Chenevert TL Ross BD Rehemtulla A Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proc Natl Acad Sci USA 2000, 97:1754-1759. 26508 10677530
40. Keane MM Ettenberg SA Nau MM Russell EK Lipkowitz S Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res 1999, 59:734-741. 9973225
41. Kupchan SM Bryan RF Gilmore CJ Dailey RG Court WA Tumor inhibitors. 74. triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from tripterygium-wilfordii J Am Chem Soc 1972, 94:7194-5. 5072337
42. Frese S Pirnia F Miescher D Krajewski S Borner MM Reed JC Schmid RA PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2 Oncogene 2003, 22:5427-5435. 12934102
43. Lee KY Chang WT Qiu DM Kao PN Rosen GD PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells J Biol Chem 1999, 274:13451-13455. 10224110
44. Chang WT Kang JJ Lee KY Wei K Anderson E Gotmare S Ross JA Rosen GD Triptolide and chemotherapy cooperate in tumor cell apoptosis - A role for the p53 pathway J Biol Chem 2001, 276:2221-2227. 11053449
45. Sprick MR Weigand MA Rieser E Rauch CT Juo P Blenis J Krammer PH Walczak H FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 Immunity 2000, 12:599-609. 10894160
46. Kischkel FC Lawrence DA Chuntharapai A Schow P Kim KJ Ashkenazi A Apo2L/ TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 2000, 12:611-620. 10894161
47. Walczak H Krammer PH The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems Exp Cell Res 2000, 256:58-66. 10739652
48. Carter BZ Mak DH Schober WD McQueen T Harris D Estrov Z Evans RL Andreeff M Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells Blood 2006, 108:630-637. 1895484 16556893
49. Daniel PT A TRAIL to Chinese herbal medicine Blood 2006, 108:3634.
50. Folkman J Bach M Rowe JW Davidoff F Lambert P Hirsch C Goldberg A Hiatt HH Glass J Henshaw E Tumor angiogenesis - therapeutic implications N Engl J Med 1971, 285:1182. 4938153
51. Yance DR Jr Sagar SM Targeting angiogenesis with integrative cancer therapies Integr Cancer Ther 2006, 5:9-29. 16484711
52. Shweiki D Itin A Soffer D Keshet E Vascular endothelial growth-factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 1992, 359:843-845. 1279431
53. Shima DT Deutsch U Damore PA Hypoxic induction of vascular endothelial growth-factor (VEGF) in human epithelial-cells is mediated by increases in messenger-RNA stability FEBS Lett 1995, 370:203-208. 7656977
54. Risau W Mechanisms of angiogenesis Nature 1997, 386:671-674. 9109485
55. Toi M Matsumoto T Bando H Vascular endothelial growth factor: Its prognostic, predictive, and therapeutic implications Lancet Oncol 2001, 2:667-673. 11902537
56. Efferth T Dunstan H Sauerbrey A Miyachi H Chitambar CR The anti-malarial artesunate is also active against cancer Int J Oncol 2001, 18:767-773. 11251172
57. Efferth T Davey M Olbrich A Rucker G Gebhart E Davey R Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells Blood Cells Molecules and Diseases 2002, 28:160-168.
58. Mueller MS Runyambo N Wagner I Borrmann S Dietz K Heide L Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria Trans R Soc Trop Med Hyg 2004, 98:318-321. 15109558
59. Chen HH Zhou HJ Wu GD Lou XE Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1 Pharmacology 2004, 71:1-9. 15051917
60. Zhou H-J Wang W-Q Wu G-D Lee J Li A Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells Vascul Pharmacol 2007, 47:131-138. 17581794
61. Chen HH Zhou HJ Fan X Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro Pharmacol Res 2003, 48:231-236. 12860439
62. Efferth T Sauerbrey A Olbrich A Gebhart E Rauch P Weber HO Hengstler JG Halatsch ME Volm M Tew KD et al. Molecular modes of action of artesunate in tumor cell lines Mol Pharmacol 2003, 64:382-394. 12869643
63. Narayan S Curcumin, A Multi-Functional Chemopreventive Agent, Blocks Growth of Colon Cancer Cells by Targeting β-Catenin-Mediated Transactivation and Cell-Cell Adhesion Pathways J Mol Histol 2004, 35:301-307. 15339049
64. Sen S Sharma H Singh N Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway Biochem Biophys Res Commun 2005 , 331:1245-1252. 15883009
65. Khafif A Hurst R Kyker K Fliss Dan M Gil Z Medina Jesus E Curcumin: A new radio-sensitizer of squamous cell carcinoma cells Otolaryngol Head Neck Surg 2005, 132:317-321. 15692547
66. Arbiser JL Klauber N Rohan R Van Leeuwen R Huang M-T Fisher C Flynn E Byers HR Curcumin is an in vivo inhibitor of angiogenesis Molecular Medicine 1998, 4:376-383. 2230271 10780880
67. Shao ZM Shen ZZ Liu CH Sartippour MR Go VL Heber D Nguyen M Curcumin exerts multiple suppressive effects on human breast carcinoma cells Int J Cancer 2002, 98:234-240. 11857414
68. Stetler-Stevenson WG Yu AE Proteases in invasion: Matrix metalloproteinases Semin Cancer Biol 2001, 11:143-153. 11322833
69. Stetler-Stevenson WG Seo D-W Matrix metalloproteinases in tumor progression Cancer Metastasis - Biology and Treatment 2006, 8:143-158.
70. Chen H-W Yu S-L Chen JJW Li H-N Lin Y-C Yao P-L Chou H-Y Chien C-T Chen W-J Lee Y-T Yang P-C Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis Mol Pharmacol 2004, 65:99-110. 14722241
71. Gururaj AE Belakavadi M Venkatesh DA Marme D Salimath BP Molecular mechanisms of anti-angiogenic effect of curcumin Biochem Biophys Res Commun 2002, 297:934-942. 12359244
72. Bachmeier BE Nerlich AG Iancu CM Cilli M Schleicher E Vene R Dell'Eva R Jochum M Albini A Pfeffer U The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice Cell Physiol Biochem 2007, 19:137-152. 17310108
73. Reddy S Aggarwal BB Curcumin is a noncompetitive and selective inhibitor of phosphorylase-kinase FEBS Lett 1994, 341:19-22. 7511111
74. Dorai T Cao YC Dorai B Buttyan R Katz AE Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo Prostate 2001, 47:293-303. 11398177
75. Leu TH Su SL Chuang YC Maa MC Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity Biochem Pharmacol 2003 , 66:2323-2331. 14637190
76. Kim JH Shim JS Lee SK Kim KW Rha SY Chung HC Kwon HJ Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: Crucial involvement of the down-regulation of matrix metalloproteinase Jpn J Cancer Res 2002, 93:1378-1385. 12495478
77. Shim JS Kim DH Jung HJ Kim JH Lim D Lee SK Kim KW Ahn JW Yoo JS Rho JR et al. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation Bioorg Med Chem 2002, 10:2987-2992. 12110321
78. John VD Kuttan G Krishnankutty K Anti-tumour studies of metal chelates of synthetic curcuminoids J Exp Clin Cancer Res 2002, 21:219-224. 12148581
79. Shi Z-M Tian J-H Correlative factors for cancer response evaluation treated by TCM Shanghai Journal of Traditional Chinese Medicine 2006, 40:16-18.
80. Li Y Ming Y-W Molecular mechanism of Chinese anti-tumor herbal medicine Chinese Journal of Information on TCM 2005, 12:95-96.
81. Kaye SB Progress in the treatment of ovarian cancer Anticancer Drugs 1999, 10:S29-S32. 10630366
82. Wang S-Z Yang J-Y Development of Clinical Applications for Anti-tumor Botanicals and Semi-Synthetic Medicine Journal of Xin Jiang Medical University 2001, 24:183-184.
83. Zheng X He M-X Bin L Effects of elemene combined with chemotherapy drugs on the growth of cancer cells Cancer Prevention and Control Research 1998, 25:220-221.
84. Li J Liang N Mo L He C Zhang X Effect of compound 6F isolated from Pteris semipinnata on cell cycle and synthesis of DNA, RNA and protein of lung adenocarcinoma cell Chinese Pharmacology 1999, 15:49-51.
85. Zhang J Mao Q Xu N Chen J Effect of berbamine derivative (EBB) on anticancer and immune function of tumor-bearing mice Chinese Herbal Journal 1998, 29:243-246.
86. Chen J-L Jiang S Yang R-F Liu F-S Sun X-M Mechanism of drug resistance and reversal with ligustrazine and cyclosporin A in cisplatin-induced human epithelial ovarian cancer resistant cell line 3Ao/cDDP Chinese Journal of Cancer Research 2000, 12:197-203.
87. Kim S-H Yeo G-S Lim Y-S Kang C-D Kim C-M Chung B-S Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells Exp Mol Med 1998, 30:87-92. 9873828
88. Kim S-W Kwon H-y Chi D-W Shim J-H Park J-D Lee Y-H Pyo S Rhee D-K Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3 Biochem Pharmacol 2003, 65:75-82. 12473381
89. Grossarth-Maticek R Kiene H Baumgartner SM Ziegler R Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study Altern Ther Health Med 2001, 7:57. 11347286
90. Grossarth-Maticek R Ziegler R Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): A re-analysis Eur J Med Res 2006, 11:485-495. 17182361
91. Parekh HS The advance of dendrimers - a versatile targeting platform for gene/drug delivery Curr Pharm Des 2007, 13:2837-2850. 17897027
92. Petrak K Essential properties of drug-targeting delivery systems Drug Discov Today 2005, 10:1667-1673. 16376827
93. Wang MD Shin DM Simons JW Nie S Nanotechnology for targeted cancer therapy Expert Rev Anticancer Ther 2007, 7:833-837. 17555393